"Legal Storm Brews: BioZorb Device Faces Backlash as Breast Cancer Survivors File Lawsuits Against Hologic"

Boston, Mass. — Women treated for breast cancer are at the center of ongoing lawsuits against Hologic, Inc. over allegations that its BioZorb Marker, a device designed to assist in post-surgical monitoring of tumor sites, has caused serious health complications. Legal action commenced in the U.S. District Court for Massachusetts in November 2022, following mounting reports of injuries allegedly linked to the BioZorb Marker, a small, coiled device with titanium clips. In early 2024, Hologic issued a safety notification, alerting healthcare providers to the risks associated with the product, prompting more attorneys to take on … Read more